Loss of Cdkn1a protects against MASLD alone or with alcohol intake by preserving lipid homeostasis
Background & Aims: Expression of P21, encoded by the CDKN1A gene, has been associated with fibrosis progression in steatotic liver disease (SLD); however, the underlying mechanisms remain unknown. In the present study, we investigated the function of CDKN1A in SLD. Methods: CDKN1A expression...
Saved in:
Similar Items
-
Development of a novel deep learning method that transforms tabular input variables into images for the prediction of SLD
by: Gabriel Cubillos, et al.
Published: (2025-07-01) -
Current burden of MASLD, MetALD, and hepatic fibrosis among US adults with prediabetes and diabetes, 2017–2023
by: Donghee Kim, et al.
Published: (2025-07-01) -
Addressing the burden of steatotic liver disease: The role of transient elastography: Correspondence to editorial on “Current burden of steatotic liver disease and fibrosis among adults in the United States, 2017-2023”
by: Donghee Kim, et al.
Published: (2025-04-01) -
Cognitive profiles in bilingual children born to immigrant parents and Italian monolingual native children with specific learning disorders
by: Riva A, et al.
Published: (2016-12-01) -
The burden of steatotic liver disease before and during the COVID-19 pandemic: Correspondence to editorial on “Current burden of steatotic liver disease and fibrosis among adults in the United States, 2017-2023”
by: Donghee Kim, et al.
Published: (2025-04-01)